Related Experiment Video
Updated: Mar 7, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes
Jesús Madero-Pérez1, Elena Fdez1, Belén Fernández1
1Institute of Parasitology and Biomedicine 'López-Neyra', Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, Granada 18016, Spain.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is a key player in the pathogenesis of Parkinson's disease. Mutations in LRRK2 are associated with increased kinase activity that correlates with cytotoxicity, indicating that kinase inhibitors may comprise promising disease-modifying compounds. However, before embarking on such strategies, detailed knowledge of the cellular deficits mediated by pathogenic LRRK2 in the context of defined and pathologically relevant kinase substrates is essential. LRRK2 has been consistently shown to impair various intracellular vesicular trafficking events, and recent studies have shown that LRRK2 can phosphorylate a subset of proteins that are intricately implicated in those processes. In light of these findings, we here review the link between cellular deficits in intracellular trafficking pathways and the LRRK2-mediated phosphorylation of those newly identified substrates.
Insights
Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease pathogenesis. This review links LRRK2's role in cellular trafficking deficits to its newly identified kinase substrates.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a key factor in Parkinson's disease (PD) development.
- LRRK2 mutations increase its kinase activity, leading to cytotoxicity, suggesting kinase inhibitors as potential therapeutics.
- Understanding cellular deficits caused by pathogenic LRRK2 and its substrates is crucial for developing effective treatments.
Purpose of the Study:
- To review the connection between intracellular trafficking defects and LRRK2-mediated phosphorylation.
- To highlight newly identified LRRK2 kinase substrates involved in cellular processes.
Main Methods:
- Literature review of studies on LRRK2, Parkinson's disease, and intracellular trafficking.
- Analysis of recent findings on LRRK2 phosphorylation targets.
- Synthesis of information linking LRRK2 activity to cellular dysfunction.
Main Results:
- LRRK2 is consistently shown to impair intracellular vesicular trafficking.
- A subset of proteins critical for trafficking are phosphorylated by LRRK2.
- These substrates are intricately involved in the cellular deficits observed in PD.
Conclusions:
- Pathogenic LRRK2 disrupts cellular functions through the phosphorylation of specific trafficking-related substrates.
- Targeting LRRK2 kinase activity or its substrates may offer disease-modifying strategies for Parkinson's disease.
- Further research into LRRK2 substrates is essential for understanding PD pathogenesis and developing novel therapies.
Related Concept Videos
Lysosomal Hydrolases
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...

